C 0001620524 XXXXXXXX LIVE false false false NeXtGen Biologics, INC Corporation DE 04-29-2014 13709 PROGRESS BLVD. BOX 11 ALACHUA FL 32615 https://www.nextgenbiologics.com/ N OpenDeal Portal LLC 0001751525 007-00167 283874 At the conclusion of the offering, the issuer shall pay a fee of six percent (6%) of the amount raised in the offering to the Intermediary. The Intermediary will also receive compensation in the form of securities equal to two percent (2%) of the total number of the securities sold in the offering. Other Crowd SAFE (Simple Agreement for Future Equity) 25000 1.00000 Arbitrary 25000.00 Y Other At the Intermediary's discretion 5000000.00 02-28-2023 9.00 1547848.00 2069171.00 337233.00 516897.00 0.00 0.00 9761500.00 9110917.00 0.00 155400.00 0.00 0.00 0.00 0.00 -110221.00 51772.00 -2007144.00 -790983.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY NeXtGen Biologics, INC Jonelle Toothman Director, Chief Executive Officer, President and Secretary Jonelle Toothman Director, Chief Executive Officer, President and Secretary 08-30-2022 Elad Levy Director 08-30-2022 Gerald Kluft Director 08-31-2022 Brian Lipke Director 08-31-2022 Jamie Grooms Director 08-30-2022 Sherrick Wassel Director 08-30-2022 Daniel Hamister Director 08-30-2022